Furthermore, we also assessed the pancreatic expression of PrP in subjects with AD, PD, DLB or T2DM and its interaction, both in the pancreas and brain, with α-synuclein, tau, Aβ and amylin. This evidence concerns the gene MAPT and Alzheimer disease.